Published in J Clin Neurosci on July 01, 2013
Assessment of visual and auditory evoked potentials in multiple sclerosis patients with and without fatigue. Neurol Sci (2014) 0.79
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis. BMC Neurol (2016) 0.78
Visual pathways involvement in clinically isolated syndrome in children. Int J Ophthalmol (2015) 0.75
Distinguishing Susac's syndrome from multiple sclerosis. J Neurol (2014) 0.75
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol (2013) 2.52
Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol (2009) 2.01
Botulinum toxin modulates cortical maladaptation in post-stroke spasticity. Muscle Nerve (2013) 2.00
Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 1.75
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet (2010) 1.73
Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol (2011) 1.59
Split-hand index for the diagnosis of amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.52
Changes in human sensory axonal excitability induced by an ischaemic insult. Clin Neurophysiol (2008) 1.49
Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.49
FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry (2009) 1.44
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis. Pathology (2012) 1.41
Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy. Clin Neurophysiol (2010) 1.41
Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol (2008) 1.39
Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry (2005) 1.34
Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry (2007) 1.33
Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage (2006) 1.31
Motor neuron dysfunction in frontotemporal dementia. Brain (2011) 1.31
An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation. Hum Mol Genet (2012) 1.25
Transsynaptic retinal degeneration in optic neuropathies: optical coherence tomography study. Invest Ophthalmol Vis Sci (2012) 1.03
Treatment of proximal upper limb tremor with botulinum toxin therapy. Mov Disord (2013) 0.97
Interrelationship of optical coherence tomography and multifocal visual-evoked potentials after optic neuritis. Invest Ophthalmol Vis Sci (2009) 0.96
Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia. Brain (2010) 0.95
Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol (2014) 0.94
Grey matter deficits and symptom profile in first episode schizophrenia. Psychiatry Res (2005) 0.94
Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry (2013) 0.92
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent. Ann Neurol (2014) 0.91
Neurophysiological index as a biomarker for ALS progression: validity of mixed effects models. Amyotroph Lateral Scler (2011) 0.91
The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform. PLoS One (2013) 0.90
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis. PLoS One (2013) 0.89
The case of a 48 year-old woman with bizarre and complex delusions. Nat Rev Neurol (2010) 0.89
Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy. J Pediatr (2012) 0.89
Remyelination of optic nerve lesions: spatial and temporal factors. Mult Scler (2010) 0.89
Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential. Neurology (2012) 0.88
Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.88
Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes. PLoS One (2011) 0.87
Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis. PLoS One (2013) 0.86
The puzzling case of hyperexcitability in amyotrophic lateral sclerosis. J Clin Neurol (2013) 0.86
Neural synchrony in patients with a first episode of schizophrenia: tracking relations with grey matter and symptom profile. J Psychiatry Neurosci (2009) 0.86
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season. Mult Scler (2013) 0.85
The relationship between cortical and spinal hyperexcitability and clinical disease severity in stiff-man syndrome. Parkinsonism Relat Disord (2012) 0.85
The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1. Hum Brain Mapp (2013) 0.85
Cortical dysfunction underlies disability in multiple sclerosis. Mult Scler (2011) 0.84
Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy. Brain (2011) 0.84
Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis. J Neurol (2015) 0.84
A rare presentation of pigmented villonodular synovitis. J Clin Neurosci (2007) 0.83
Synovial chondrosarcoma arising in synovial chondromatosis of the temporomandibular joint. Head Neck Pathol (2013) 0.83
Motor cortex excitability in acute cerebellar infarct. Cerebellum (2013) 0.83
Ischaemic sensitivity of axons in carpal tunnel syndrome. J Peripher Nerv Syst (2009) 0.83
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain (2013) 0.83
Facial onset sensory and motor neuronopathy (FOSMN) of childhood onset. Muscle Nerve (2014) 0.83
Identification of Staphylococcus aureus brain abscesses: rat and human studies with 1H MR spectroscopy. Radiology (2005) 0.83
Severe Guillain-Barré syndrome following head trauma. J Clin Neurosci (2010) 0.82
Evoked potentials elicited by stimulation of the lateral and anterior femoral cutaneous nerves in meralgia paresthetica. Muscle Nerve (2004) 0.82
Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy. Muscle Nerve (2008) 0.82
Polyglucosan body disease myopathy: an unusual presentation. Muscle Nerve (2007) 0.82
Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Rev Neurother (2015) 0.81
Automated generation of curved planar reformations from MR images of the spine. Phys Med Biol (2007) 0.81
Cortical excitability differences in hand muscles follow a split-hand pattern in healthy controls. Muscle Nerve (2014) 0.81
Corticospinal tract dysfunction and development of amyotrophic lateral sclerosis following electrical injury. Muscle Nerve (2010) 0.81
Delusions and dorso-medial frontal cortex volume in first-episode schizophrenia: a voxel-based morphometry study. Psychiatry Res (2009) 0.81
Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler (2013) 0.80
Cerebral nocardiosis characterized by magnetic resonance spectroscopy in vivo. Clin Infect Dis (2002) 0.80
Treatment update in multiple sclerosis. Curr Allergy Asthma Rep (2012) 0.80
A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.80
Longitudinal plasticity across the neural axis in acute stroke. Neurorehabil Neural Repair (2012) 0.80
Corticomotoneuronal integrity and adaptation in spinal muscular atrophy. Arch Neurol (2012) 0.78
The effects of large artery ischemia and subsequent recanalization on nerve excitability. Muscle Nerve (2011) 0.78
The re-emergence of evoked potentials in multiple sclerosis; from diagnosis to prognostication. Clin Neurophysiol (2011) 0.78
Split-hand plus sign in ALS: differential involvement of the flexor pollicis longus and intrinsic hand muscles. Amyotroph Lateral Scler Frontotemporal Degener (2012) 0.78
Fasciculation potentials: a diagnostic biomarker of early ALS? J Neurol Neurosurg Psychiatry (2013) 0.78
Clinical profiles, scope and general findings of the Western Sydney First Episode Psychosis Project. Aust N Z J Psychiatry (2005) 0.77
Upregulation of inward rectifying currents and Fabry disease neuropathy. J Peripher Nerv Syst (2012) 0.77
Cortical excitability differences between flexor pollicis longus and APB. Neurosci Lett (2013) 0.77
Longitudinal changes in neuroanatomy and neural activity in early schizophrenia. Neuroreport (2007) 0.77
Skull base chordoid meningioma: imaging features and pathology. Australas Radiol (2004) 0.76
Transynaptic changes evident in peripheral axonal function after acute cerebellar infarct. Cerebellum (2014) 0.76
The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 0.76
Assessing motor unit firing rates in ALS: A diagnostic and pathophysiological prospect? Clin Neurophysiol (2012) 0.75
Insights into the mechanisms underlying cortical plasticity following spinal cord injury. Clin Neurophysiol (2011) 0.75
Corticomotoneuronal dysfunction: a process specific to amyotrophic lateral sclerosis? Clin Neurophysiol (2009) 0.75
Heterogeneity of pathological processes in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry (2011) 0.75
Cortical hyperexcitability and the split-hand plus phenomenon: pathophysiological insights in ALS. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.75
Phrenic nerve compound muscle action potential amplitude: biomarker of disease progression in ALS? Clin Neurophysiol (2009) 0.75
Jugular Foramen Ganglioneuroma Presenting Radiographically as Schwannoma. Otol Neurotol (2016) 0.75
Extensive Postradiation Ocular and Diffuse Cranial Neuromyotonia Mimicking Myasthenia Gravis. Neurologist (2016) 0.75
Anterior interosseous nerve conduction study: normative data. Muscle Nerve (2007) 0.75
Generation of curved planar reformations from magnetic resonance images of the spine. Med Image Comput Comput Assist Interv (2006) 0.75
Significant dermatological side effects of intravenous immunoglobulin. J Clin Neurosci (2013) 0.75
Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase. J Neurol (2013) 0.75
Distinguishing Susac's syndrome from multiple sclerosis. J Neurol (2014) 0.75
Temporal bone chondroblastoma. Otol Neurotol (2009) 0.75
Progressive meningoencephalitis in a Sudanese immigrant. Med J Aust (2010) 0.75